PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3847525-0	1985	[Effect of BRL 25000 (clavulanic acid-amoxicillin) on bacterial flora in human feces].	Clavulanic Acid	22-37	bromodomain containing 1	Homo sapiens	11-14	
3499526-0	1987	[Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of pelvioperitonitis and Douglas" abscess].	Clavulanic Acid	32-47	bromodomain containing 1	Homo sapiens	21-24	
3488425-7	1986	Against the B. fragilis group, BRL 25000 was much more active than AMPC or any of the cephalosporins tested, clearly demonstrating the beta-lactamase inhibitory properties of the clavulanic acid in BRL 25000.	Clavulanic Acid	179-194	bromodomain containing 1	Homo sapiens	31-34	
3488425-7	1986	Against the B. fragilis group, BRL 25000 was much more active than AMPC or any of the cephalosporins tested, clearly demonstrating the beta-lactamase inhibitory properties of the clavulanic acid in BRL 25000.	Clavulanic Acid	179-194	bromodomain containing 1	Homo sapiens	198-201	
6876360-1	1983	BRL 25000, consisting of 250 mg amoxicillin (AMPC) and 125 mg clavulanic acid (CVA), was studied in the field of obstetrics and gynecology.	Clavulanic Acid	62-77	bromodomain containing 1	Homo sapiens	0-3	
6876360-1	1983	BRL 25000, consisting of 250 mg amoxicillin (AMPC) and 125 mg clavulanic acid (CVA), was studied in the field of obstetrics and gynecology.	Clavulanic Acid	79-82	bromodomain containing 1	Homo sapiens	0-3